人民网香港9月10日电 乙型肝炎影响香港1/10的人口，令这些受感染者患肝癌的机会比常人高出超过100倍。Network hepatitis B in Hong Kong on September 10 -- one tenth of the population of Hong Kong. those infected with the liver more than one hundred times higher than those of ordinary people. 医学界一向认为乙型肝炎病毒无法清除，不过香港大学的研究发现，抗病毒药拉米夫丁(Lamivudine)能够把浓度极高的乙型肝炎带毒赶尽杀绝；另一方面，少数乙型肝炎带菌者可靠持续服药而将血内病毒清除，只是1/3的肝脏组织仍潜藏病毒DNA，即肝癌风险并无减少。That the medical profession has been unable to eliminate hepatitis B virus, but the University of Hong Kong, the study found that antiviral drug Lamivudine (Lamivudine), a high concentration of the hepatitis B virus can ruthless; the other hand, continued a few reliable carriers of hepatitis B virus medication and to remove blood, only one-third of the liver is still hidden virus DNA that does not reduce the risk of liver cancer.

　　港大医学院昨天发表有关乙型肝炎的最新研究结果。Faculty of Medicine of the University of Hong Kong yesterday published the results of the latest research on hepatitis B. 港大内科学系讲座教授黎青龙透露，188 名乙型肝炎病人早前试用抗病毒新药拉米夫丁(怡干乐)，结果两名分别19和23岁的病人用后发现血液内的病毒完全消失，其中1名病人的肝组织化验亦证实体内无潜藏病毒。HKU Science Professor Li Qinglong, the 188 hepatitis B patients earlier trial antiviral drug Lamivudine (Yue Yue) The results of two patients, aged 19 and 23 were found with the virus in blood completely disappeared, One of the patient's liver in vivo tests also confirmed that no hidden virus. 他说，从没有见过如此年轻的患者可清除体内病毒，因此相信药物有机会把病毒杀灭。He said, and I have never seen such young patients can be rid of viruses, it is believed that the virus would kill organic substances.

　　港大内科学系名誉临床副教授袁孟峰补充说，香港市民感染乙型肝炎病毒的年龄一般为0至5岁，每1万名患者可能有1人可自行令病毒消失，原因未明，他们唯一的共通点是感染的乙肝病毒属于B型(共有A至F型)；而华人乙型肝炎带菌者之中，只有1/4是感染B型。Science, honorary clinical associate professor with the University of Hong Kong Meng Feng added that Hong Kong people infected with hepatitis B virus in an age of 0-5 years. 1 per 10,000 patients who may have the virus may disappear, the reasons are unclear, the only thing they have in common is Type B. hepatitis B virus infection (a total of A to F); Hepatitis B carriers and the Chinese, only one-quarter are type B infection.

　　同时，他们最新发表的研究显示，在3800多名由玛丽医院跟进的乙肝带菌者之中，有92人(平均年龄49岁)的验血报告显示不含病毒，只是34人被发现肝组织内藏有由乙肝病毒转化的共价闭合环状脱氧核醣核酸(cccDNA)，反映他们的肝癌风险与血含菌的病人无异。Also, they recently released study shows that in 3800 the number of hepatitis B carriers by the follow-up to Queen Mary Hospital, 92 (average age 49 years) blood test revealed no virus, only 34 were found inside the liver tissue from the hepatitis B virus into covalently closed circular DNA (cccDNA). They reflect the risk of liver cancer patients with the blood of the same bacteria.

　　黎青龙呼吁，乙肝病人需每半年进行1次血液、甲胎蛋白和超声波检验，即使血内病毒能够清除，也要以超声波监察有否早期肝癌病征。Li Qinglong called hepatitis B patients required every six months for one blood test and ultrasound AFP. Even blood virus removal, but also to monitor whether ultrasound early symptoms of liver cancer. （刘韬）(Liu Tao)